Opening book details…
About this book
Development of a Nitrene-Type Rearrangement for the Commercial Route of the JAK1 Inhibitor Abrocitinib by Christina G. Connor, Jacob C. DeForest, Phil Dietrich, Nga M. Do, Kevin M. Doyle, Shane Eisenbeis, Elizabeth Greenberg, Sarah H. Griffin, Brian P. Jones, Kris N. Jones, Michael Karmilowicz, Rajesh Kumar, Chad A. Lewis, Emma L. McInturff, J. Christopher... is a book available to read on EtoBox.
- Author
- Christina G. Connor, Jacob C. DeForest, Phil Dietrich, Nga M. Do, Kevin M. Doyle, Shane Eisenbeis, Elizabeth Greenberg, Sarah H. Griffin, Brian P. Jones, Kris N. Jones, Michael Karmilowicz, Rajesh Kumar, Chad A. Lewis, Emma L. McInturff, J. Christopher...
- Published
- 2021
- Language
- EN
More by Christina G. Connor, Jacob C. DeForest, Phil Dietrich, Nga M. Do, Kevin M. Doyle, Shane Eisenbeis, Elizabeth Greenberg, Sarah H. Griffin, Brian P. Jones, Kris N. Jones, Michael Karmilowicz, Rajesh Kumar, Chad A. Lewis, Emma L. McInturff, J. Christopher...
Similar books
- Efficient, Protecting Group Free Kilogram-Scale Synthesis of the JAK1 Inhibitor GDC-4379 — Andreas Stumpf, Johannes Burkhard, Di Xu, Andreas Marx, David Lao, Miriam Ochsenbein, Rohit Ranjan, Remy Angelaud & Francis Gosselin (2021)
- Development of a Synthesis Process for a Novel HCV NS5A Inhibitor, Emitasvir — Hongming Xie, Haiwang Liu, Yingjun Zhang, Enhuo Huang, Yahui Feng, Xuwen Xiang, Qinghong Fang, Zhihong Peng, Wanrong Dong & Delie An (2021)
- Development of a Commercial Manufacturing Route to 2-Fluoroadenine, The Key Unnatural Nucleobase of Islatravir — Cynthia M. Hong, Yingju Xu, John Y. L. Chung, Danielle M. Schultz, Mark Weisel, Richard J. Varsolona, Yong-Li Zhong, Akasha K. Purohit, Cyndi Q. He, Donald R. Gauthier, Guy R. Humphrey, Kevin M. Maloney, François Lévesque, Zhixun Wang, Aaron M.... (2021)
- Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir — Weihong Zhang, Shixi Li, Haiwang Liu, Yingjun Zhang, Hongpeng Xie, Dahua Peng, Hongtao Peng, Zijian Ou, Zhihong Peng, Wanrong Dong & Delie An (2022)
- Application of C–H Functionalization in the Development of a Concise and Convergent Route to the Phosphatidylinositol-3-kinase Delta Inhibitor Nemiralisib — Robert N. Bream, Hugh Clark, Dean Edney, Antal Harsanyi, John Hayler, Alan Ironmonger, Nadine Mc Cleary, Natalie Phillips, Catherine Priestley, Alastair Roberts, Philip Rushworth, Peter Szeto, Michael R. Webb & Katherine Wheelhouse (2021)
- Development of a Robust Manufacturing Route for Molnupiravir, an Antiviral for the Treatment of COVID-19 — Patrick S. Fier, Yingju Xu, Marc Poirier, Gilmar Brito, Michelle Zheng, Rachel Bade, Eric Sirota, Kevin Stone, Lushi Tan, Guy R. Humphrey, Darryl Chang, Jameson Bothe, Yongqian Zhang, Frank Bernardoni, Steve Castro, Michael A. Zompa, Jerry Taylor,... (2021)